
201 - 500 funcionários
Fundada em 2017
🧬 Biotecnologia
💊 Farmacêutico
Biotechnology • Pharmaceuticals
A Allogene Therapeutics é uma empresa de biotecnologia em estágio clínico, com sede em South San Francisco, que desenvolve terapias de células T com receptor de antígeno quimérico alogênico (AlloCAR T) para câncer e doenças autoimunes. A empresa foca em imunoterapia e oncologia, aproveitando abordagens de CAR T prontos para uso a fim de criar produtos de terapia celular alogênica direcionados a malignidades hematológicas e, potencialmente, a indicações autoimunes.
🕒 Julho 27
🏄 California – Remoto
💵 $280.000 - $320.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 21%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

201 - 500 funcionários
Fundada em 2017
🧬 Biotecnologia
💊 Farmacêutico
Biotechnology • Pharmaceuticals
A Allogene Therapeutics é uma empresa de biotecnologia em estágio clínico, com sede em South San Francisco, que desenvolve terapias de células T com receptor de antígeno quimérico alogênico (AlloCAR T) para câncer e doenças autoimunes. A empresa foca em imunoterapia e oncologia, aproveitando abordagens de CAR T prontos para uso a fim de criar produtos de terapia celular alogênica direcionados a malignidades hematológicas e, potencialmente, a indicações autoimunes.
• Develop and execute a comprehensive market access strategy, including pricing, reimbursement, and payer engagement, to support launch and lifecycle management of allogeneic CAR T therapies • Lead cross-functional development of payer value propositions, access strategies, and evidence plans aligned with clinical and commercial objectives • Establish and maintain relationships with national and regional payers, including commercial insurers, Medicare Advantage, Medicaid, and employer groups, to secure favorable coverage and reimbursement • Lead negotiation of coverage policies, reimbursement terms, single case agreements, and contract strategies specific to cell therapy delivery • Design and implement access strategies that address CAR T–specific site-of-care requirements, including academic centers, community oncology practices, and evolving outpatient delivery models • Monitor and influence payer and government policy, including CMS and state Medicaid developments, to address access barriers and support patient access • Develop and implement innovative payment models and contracting approaches to support high-cost, one-time therapies • Build and lead a field reimbursement organization to support providers navigating complex CAR T access pathways • Design and implement patient support services to facilitate access, including benefits verification, reimbursement support, and care coordination • Partner with Supply Chain and Commercial teams to develop distribution and channel strategies aligned with cell therapy logistics and treatment center capabilities • Track payer coverage, reimbursement trends, COE network requirements, and competitive dynamics to inform strategy • Provide strategic input into business development and financial planning related to pricing, access, and reimbursement • Ensure all market access activities comply with relevant regulations and industry standards • Other duties as assigned
• Bachelor’s, Master’s or Pharm.D. degree in Life Sciences or related field (or relevant experience) • 15+ years of experience in market access, pricing, reimbursement, or related roles within biotech or pharmaceutical industry, including leadership experience • Demonstrated experience developing and executing market access strategy for oncology or specialty therapies, with direct experience in CAR T or cell therapy strongly preferred • Deep understanding of CAR T reimbursement dynamics, including single case agreements, site-of-care considerations, and COE network requirements • Experience working across both academic medical centers and community oncology settings • Strong understanding of innovative payment models and access considerations for high-cost, one-time therapies • Knowledge of oncology clinical data and health economics to support value-based discussions • Proven ability to lead cross-functional initiatives and influence senior stakeholders • Strong negotiation, communication, and analytical skills • Ability to operate effectively in a fast-paced, high-growth biotech environment • Strong financial management and business acumen • Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines • Strong interpersonal skills including verbal and written communication are essential in this collaborative work environment • Candidates must be authorized to work in the U.S.
• annual performance bonus • equity • health insurance • generous time off (including 2 annual holiday company-wide shutdowns)
Candidatar-se🕒 Julho 27
Health Systems Director managing sales and access strategies for SOBI Rare Disease products. This role focuses on achieving objectives within assigned health systems and institutions.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 25
Executive Technical Director leading engineering practice at Instrument. Guiding technical strategy across complex digital experiences and defining AI-enabled software roles.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $280.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 24
Director of Revenue Cycle leading strategic direction and performance of revenue operations in a virtual medical practice. Drive innovation and ensure alignment between financial performance and patient experience.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $32.000.000 Series A em 2025-06
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 24
Director of Value & Access developing and executing access strategies for oncology diagnostics and computational pathology solutions at Danaher. Leading cross-functional teams and shaping payer engagement strategies across multiple geographies.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $160.000 - $220.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 24
Director, HEOR & RWE leading health economics and outcomes research strategies for Zealand Pharma. Generating real-world evidence and collaborating with stakeholders to demonstrate product value.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $210.000 - $250.000 / ano
💰 $4.137.483 Post-IPO Equity - Zealand Pharma em 2025-06
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório